Altamira Therapeutics Ltd (NASDAQ: CYTO) is -86.67% lower on its value in year-to-date trading and has touched a low of $0.40 and a high of $12.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CYTO stock was last observed hovering at around $0.48 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.46, the stock is 3.91% and -12.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -3.09% at the moment leaves the stock -60.66% off its SMA200. CYTO registered -92.38% loss for a year compared to 6-month loss of -68.86%. The firm has a 50-day simple moving average (SMA 50) of $0.53334 and a 200-day simple moving average (SMA200) of $1.186655.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.42% gain in the last 1 month and extending the period to 3 months gives it a -49.57%, and is 10.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.81% over the week and 12.99% over the month.
Distance from 52-week low is 16.00% and -96.38% from its 52-week high.
The EPS is expected to grow by 84.03% this year
The shares outstanding are 3.78M, and float is at 3.76M with Short Float at 2.80%.
